Shared on 01 Nov 25
Analysts have maintained their price target for PolyNovo at $1.97, reflecting a largely unchanged outlook. Modest improvements in revenue growth and profit margin offset a slight increase in discount rate assumptions.
Shared on 18 Oct 25
International Expansion And Regulatory Approvals Will Unlock New Markets
Analysts have maintained PolyNovo's fair value price target at $1.97. This reflects continued confidence in the company's prospects despite minor adjustments to certain financial assumptions.
Shared on 04 Oct 25
Fair value Increased 9.32%International Expansion And Regulatory Approvals Will Unlock New Markets
Analysts have raised their fair value price target for PolyNovo from $1.81 to $1.97 per share. This change reflects slight improvements in projected revenue growth and a marginally lower discount rate.
Shared on 26 Aug 25
Fair value Decreased 8.98%International Expansion And Regulatory Approvals Will Unlock New Markets
The consensus price target for PolyNovo has been revised downward to A$1.80, reflecting a notable drop in its future P/E multiple despite an improvement in net profit margin. Valuation Changes Summary of Valuation Changes for PolyNovo The Consensus Analyst Price Target has fallen from A$1.98 to A$1.80.
Shared on 01 May 25
Fair value Decreased 1.27%NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects
Shared on 24 Apr 25
NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Decreased 5.19%NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects
AnalystConsensusTarget has increased profit margin from 15.1% to 17.7% and decreased future PE multiple from 60.2x to 48.9x.
Shared on 09 Apr 25
NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Increased 4.77%NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.